Nonsteroidal and steroidal aromatase inhibitors in breast cancer

ONCOLOGY

Volumn 15, Issue 8, 2001, Pages 965-972

  Hamilton, Anne ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ENZYME INHIBITOR; EXEMESTANE; LETROZOLE; NITRILE; TRIAZOLE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; NEOPLASM; REVIEW;

ANDROSTADIENES; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; ENZYME INHIBITORS; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; NITRILES; TRIAZOLES;

EID: 0035430712     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Beatson GT: On the treatment of inoperable cases of carcinoma mamma: Suggestions for a new method of treatment with illustrative cases. Lancet 2:104-107, 1896.
2. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually (see comments in J Nail Cancer Inst 81:1845-1855, 1989; 82:879-882, 1990). J Natl Cancer Inst 81:1879-1886, 1989.
3. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study (see comments in J Nat Cancer Inst 91-188, 1999; 91:730, 1999; 92:659-660, 2000; 92:757-758, 2000; 92:943-944, 2000). J Natl Cancer Inst 90:1371-1388, 1998.